Evusheld 'unlikely to be active' against new COVID-19 subvariants: Health CanadaHealthcare professionals should be aware of the drug’s limitations against newer variants—and make sure they communicate them clearly to patients. New study finds fluvoxamine ineffective for mild to moderate COVID-19 in outpatientsAlthough study results have been conflicting, overall evidence does not support use of fluvoxamine for current treatment of mild to moderate COVID-19. How should acute COVID-19 be managed in children? Pediatric COVID-19 working group of AMMI Canada issues practice point on the treatment of acute COVID-19 in children. Omicron subvariant XBB.1.5 jumps from 9.9% to 40.5% of U.S. COVID cases in two weeks Concerns raised about another potential wave of COVID-19 cases following the busy holiday travel season. Patients are highly satisfied with pharmacy-based travel health services A systematic review examines the types and outcomes of pharmacist-managed travel health services The symptoms that stick around: Quebec researchers examine persistent symptoms following Omicron infection Study identifies risk factors and prevalence of ongoing symptoms after SARS-CoV-2 Omicron infection in adults. Updated recommendation on giving COVID-19 vaccines with other vaccines The NACI has announced that COVID-19 vaccines may be administered concurrently with other vaccines in all authorized age groups. Study shows importance of COVID-19 vaccine booster dose in children 5 to 11 years A booster dose of Pfizer vaccine restored protection against Omicron, with efficacy maintained for at least three months. Nuvaxovid COVID-19 vaccine approved for adolescents and for first booster dose in adults Protein subunit COVID-19 vaccine may be an option for individuals who are unable or not willing to receive an mRNA COVID-19 vaccine. Strep A and scarlet fever infections surge in U.K., drive up antibiotic demand, prices Families and pharmacists struggling to find medications as highly unusual numbers of cases occur. First Previous 32 33 34 35 36 Next Last
